Dr. Ming is an assistant professor in public health and epidemiology and the co-program leader of the MSc Public Health and Epidemiology postgraduate program at the City University of Hong Kong. He is an experienced clinical doctor and medical educator. He has over 10 years of experience teaching and mentoring students in medical school. To date, he has supervised over 100 undergraduate and graduate research students. He undertook his postdoctoral training at Oxford University and Harvard University. He completed his fellowship at the Nuffield Department of Women's & Reproductive Health, University of Oxford, and obtained a master's degree from Harvard University in the United States in 2018.
As a clinician-epidemiologist, Dr. Ming's research over the last 10 years has covered topics ranging from health policy-oriented clinical research to infectious disease control and surveillance. His research team has extensive interdisciplinary collaboration experience, including clinical research, health and pharmaceutical economics, real-world research, health policy, and artificial intelligence medicine. He has had a long history of cooperation with the United States, United Kingdom, and local universities on national-based clinical research projects. Dr Ming's current work revolves around COVID-19 research that has significant population health impacts locally and internationally. His team is the leading team in health policy research in Asia.
Dr. Ming is an assistant professor in public health and epidemiology and the co-program leader of the MSc Public Health and Epidemiology postgraduate program at the City University of Hong Kong. He is an experienced clinical doctor and medical educator. He has over 10 years of experience teaching and mentoring students in medical school. To date, he has supervised over 100 undergraduate and graduate research students. He undertook his postdoctoral training at Oxford University and Harvard University. He completed his fellowship at the Nuffield Department of Women's & Reproductive Health, University of Oxford, and obtained a master's degree from Harvard University in the United States in 2018.
As a clinician-epidemiologist, Dr. Ming's research over the last 10 years has covered topics ranging from health policy-oriented clinical research to infectious disease control and surveillance. His research team has extensive interdisciplinary collaboration experience, including clinical research, health and pharmaceutical economics, real-world research, health policy, and artificial intelligence medicine. He has had a long history of cooperation with the United States, United Kingdom, and local universities on national-based clinical research projects. Dr Ming's current work revolves around COVID-19 research that has significant population health impacts locally and internationally. His team is the leading team in health policy research in Asia.